Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc in Brussels, Belgium is listed as a site for 697 registered clinical trials, 220 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 697
Ongoing 220

This page covers the site record Cliniques Universitaires Saint-Luc in Brussels, Belgium: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Cliniques Universitaires Saint-Luc, also sponsors trials.

Get the Cliniques Universitaires Saint-Luc report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 697 trials counted.

  • Phase 1 36 trials
  • Phase 1/2 31 trials
  • Phase 2 114 trials
  • Phase 2/3 17 trials
  • Phase 3 221 trials
  • Phase 4 18 trials
  • Not applicable 165 trials
  • Observational 93 trials
  • Expanded access 2 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 220 trials
  • Completed 319 trials
  • Terminated 83 trials
  • Other 75 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 59

1992: 1 trials (Phase 3 1) 1995: 1 trials (Phase 3 1) 1996: 2 trials (Phase 3 2) 1997: 1 trials (Phase 3 1) 1998: 1 trials (Phase 3 1) 1999: 1 trials (Phase 3 1) 2000: 1 trials (Phase 3 1) 2001: 5 trials (Phase 3 3, Phase 2 1, Phase 1/2 1) 2002: 10 trials (Observational 1, Not applicable 1, Phase 3 4, Phase 2 4) 2003: 5 trials (Observational 1, Phase 3 2, Phase 2/3 1, Phase 2 1) 2004: 5 trials (Phase 3 2, Phase 2 3) 2005: 2 trials (Phase 3 1, Phase 2 1) 2006: 10 trials (Observational 1, Phase 3 6, Phase 2/3 1, Phase 2 1, Phase 1/2 1) 2007: 8 trials (Observational 2, Not applicable 1, Phase 3 3, Phase 2/3 1, Phase 2 1) 2008: 12 trials (Observational 3, Not applicable 2, Phase 4 1, Phase 3 4, Phase 2/3 1, Phase 2 1) 2009: 18 trials (Observational 1, Not applicable 5, Phase 4 1, Phase 3 7, Phase 2 3, Phase 1 1) 2010: 19 trials (Observational 2, Not applicable 2, Phase 3 10, Phase 2 3, Phase 1/2 2) 2011: 13 trials (Observational 6, Not applicable 2, Phase 3 3, Phase 2/3 1, Phase 1 1) 2012: 19 trials (Observational 3, Not applicable 6, Phase 4 1, Phase 3 4, Phase 2 4, Phase 1/2 1) 2013: 23 trials (Observational 6, Not applicable 4, Phase 4 2, Phase 3 5, Phase 2 6) 2014: 37 trials (Observational 7, Not applicable 13, Phase 4 1, Phase 3 3, Phase 2/3 2, Phase 2 9, Phase 1/2 2) 2015: 31 trials (Observational 8, Not applicable 11, Phase 4 1, Phase 3 4, Phase 2 3, Phase 1/2 2, Phase 1 2) 2016: 32 trials (Observational 4, Not applicable 8, Phase 4 1, Phase 3 8, Phase 2 7, Phase 1/2 2, Phase 1 2) 2017: 59 trials (Observational 6, Not applicable 19, Phase 4 4, Phase 3 14, Phase 2/3 1, Phase 2 9, Phase 1/2 3, Phase 1 3) 2018: 45 trials (Observational 3, Not applicable 11, Phase 4 1, Phase 3 15, Phase 2 8, Phase 1/2 3, Phase 1 4) 2019: 48 trials (Observational 5, Not applicable 14, Phase 3 6, Phase 2/3 1, Phase 2 15, Phase 1/2 5, Phase 1 2) 2020: 42 trials (Observational 6, Not applicable 10, Phase 4 1, Phase 3 13, Phase 2 8, Phase 1/2 1, Phase 1 3) 2021: 49 trials (Observational 9, Not applicable 13, Phase 3 15, Phase 2/3 1, Phase 2 9, Phase 1/2 1, Phase 1 1) 2022: 43 trials (Observational 5, Not applicable 6, Phase 3 20, Phase 2/3 1, Phase 2 7, Phase 1/2 1, Phase 1 3) 2023: 35 trials (Observational 4, Not applicable 6, Phase 4 2, Phase 3 15, Phase 2/3 3, Phase 2 1, Phase 1/2 1, Phase 1 3) 2024: 43 trials (Observational 3, Not applicable 6, Phase 4 1, Phase 3 19, Phase 2/3 1, Phase 2 5, Phase 1/2 3, Phase 1 5) 2025: 41 trials (Observational 3, Not applicable 11, Phase 3 18, Phase 2/3 2, Phase 2 3, Phase 1 4)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 32
2025 41
2024 43
2023 35
2022 43
2021 49
2020 42
2019 48
2018 45
2017 59

Showing 10 of 33 years.

Start your 14-day trial Email me all 33 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 697 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 187 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 390 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF